News Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 09:05:47 30/07/2026 pm IST			5-day change	1st Jan Change
85.00 ^CHF	-3.41%		+0.59%	-14.14%

01/08	Amgen discloses data breach involving patient health information	RE
31/07	Dexcom raises annual revenue forecast on strong demand for glucose monitors	RE

All News

Mentions Relevance

29/07	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
28/07	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
28/07	Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve	PU
28/07	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
27/07	Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment	MT
25/07	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
25/07	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
23/07	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
22/07	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
18/07	Abbott investigates two separate cyber incidents, says no operations affected	RE
17/07	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
17/07	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
17/07	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
17/07	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
17/07	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
17/07	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
17/07	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
17/07	Army integrating new handheld device to quickly assess brain injuries	AQ
17/07	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
16/07	Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise	MT
16/07	Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
16/07	Abbott Laboratories, Q2 2026 Earnings Call, Jul 16, 2026
16/07	Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views	MT
16/07	Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL	PU
16/07	Abbott Laboratories 2Q Sales Rise on Diagnostics Growth	DJ